Decoding the Pathophysiology and the Genetics of Multiple Myeloma to Identify New Therapeutic Targets-Reference-Cited by-同舟云学术

Decoding the Pathophysiology and the Genetics of Multiple Myeloma to Identify New Therapeutic Targets

Published:2013-10 Issue:5 Volume:40 Page:537-548
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Lawasut Panisinee,Groen Richard W.J.,Dhimolea Eugen,Richardson Paul G.,Anderson Kenneth C.,Mitsiades Constantine S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference126 articles.

1. Molecular pathogenesis and a consequent classification of multiple myeloma;Bergsagel;J Clin Oncol,2005

2. How to use new biology to guide therapy in multiple myeloma;Morgan;Hematology/Education Program of the American Society of Hematology American Society of Hematology Education Program,2012

3. Molecular pathogenesis of multiple myeloma and its premalignant precursor;Kuehl;J Clin Invest,2012

4. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma;Keats;Cancer Cell,2007

5. Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma;Billecke;Anticancer Res,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of DNA Repair in Genomic Instability of Multiple Myeloma;International Journal of Molecular Sciences;2022-05-19

2. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins;Blood;2018-03-01

3. Epidemiology and Pathophysiology of Multiple Myeloma;Hematologic Malignancies;2017-12-11

4. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins;Proceedings of the National Academy of Sciences;2016-12-27

5. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease;Oncogene;2016-10-24